Vimarsana
Biggest News Aggregation in the World

Page 38 - Clinical Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Program Today - Breaking & Trending Today

Queen's Birthday Honours – the Jewish list for 2022 » J-Wire - Vimarsana News

Queen's Birthday Honours – the Jewish list for 2022 » J-Wire

Members of the Australian Jewish community have received Queen's Birthday awards in the fields of philanthropy, medicine, communal involvement and arts. One awardee has been recognised for aiding refugees and joins another one for helping the reduction of smokers. J-Wire wishes them all Mazeltov.

Medtronic Announces FDA Approval for IN.PACT 018 PTA Balloon Catheter - Vimarsana News

Medtronic Announces FDA Approval for IN.PACT 018 PTA Balloon Catheter

Built on the market-leading IN.PACT Admiral DCB technology, the IN.PACT 018 DCB is engineered to cross tight lesions and designed for better deliverability

Edesa Biotech Adds Mechanically Ventilated Patients to Phase 3 ARDS Study - Vimarsana News

Edesa Biotech Adds Mechanically Ventilated Patients to Phase 3 ARDS Study

TORONTO, ON / ACCESSWIRE / May 24, 2022 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that the company

EuroPCR: Medtronic renal denervation system shows better blood pressure control with significantly more time in target range - Vimarsana News

EuroPCR: Medtronic renal denervation system shows better blood pressure control with significantly more time in target range

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Aridis Pharmaceuticals Announces First Quarter 2022 Financial Results and Business Update - Vimarsana News

Aridis Pharmaceuticals Announces First Quarter 2022 Financial Results and Business Update

/PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective...